Data Package for study.
收藏DataCite Commons2025-12-09 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00001432.0
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare gefitinib with carboplatin / paclitaxel doublet chemotherapy given as first line treatment in terms of progression free survival in selected NSCLC patients with the objective of demonstrating non-inferiority.
提供机构：
Vivli
创建时间：
2025-12-09
